Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Quantum Pharma looks to meet FY market expectations

Wed, 31st Aug 2016 11:48

(ShareCast News) - Quantum Pharma has made good progress during its first half, in line with management views, and anticipates meeting market expectations for the full year."As previously indicated, the group's performance for the year is second-half weighted and will be dependent on the level of sales achieved by recent product launches," it said.The company added that its performance was further linked to the timing and sales of further product launches due to be delivered in the remainder of the year.At about 11:50 BST, shares in Quantum were down 7.18% to 80.75p.

Related Shares

More News
20 Oct 2016 11:35

Quantum Pharma conditionally raises £15m in accelerated bookbuild

(ShareCast News) - Quantum Pharma confirms its accelerated bookbuild to raise up to £15m has closed successfully, subject to the passing of certain r...

20 Oct 2016 07:41

Quantum Pharma Raises GBP15 Million To Pay Down Debt (ALLISS)

4 Oct 2016 09:10

Quantum Pharma's shares plummet as it expects to perform below expectations in H2

(ShareCast News) - Shares in AIM-listed drug manufacturer Quantum Pharma plunged nearly 50% on Tuesday morning as it said it expects the performance i...

10 Aug 2016 07:37

Quantum Pharma's Colonis Launches Peptic Ulcer Treatment

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.